![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Using SGLT2-inhibitors to treat cardiac patients with diabetes (Ted Rogers Centre for Heart Research) View |
![]() |
SGLT2 Inhibitors and Heart Failure (Harvard Medical School Continuing Education) View |
![]() |
SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF (AJMCtv MJH) View |
![]() |
SGLT2 inhibitors and cardiovascular outcomes in type 2 diabetes: VERTIS CV trial (GPnotebook) View |
![]() |
Best Practices for Starting SGLT2 Inhibitors in HFpEF Treatment (Medscape) View |
![]() |
CV Risk in T2D: Role of SGLT2 Inhibition (HCPLive) View |
![]() |
Using GLP1 receptor agonists to treat cardiac patients with diabetes (Ted Rogers Centre for Heart Research) View |
![]() |
E139 – SGLT2 inhibitors for kidney and heart disease (Australian Prescriber) View |
![]() |
Therapy for Heart Failure w/ Reduced Ejection Fraction - When u0026 How to Introduce SGLT2 Inhibitors (Mayo Clinic) View |
![]() |
SGLT2 Inhibitors in T1D: 'People Are Using Them Now' (Medscape) View |